GPs’ advice service is causing cancer diagnoses to be missed, inquiry finds

Cancer Patients Left Waiting: England’s GP Advice Scheme Linked to Missed Diagnoses

Wanderstayfinder.com – Patients across England with suspected cancer have been left without timely diagnosis or treatment because of a well-intentioned scheme that lets family doctors consult hospital specialists before sending formal referrals. A formal investigation by the Health Services Safety Investigations Body (HSSIB) has concluded that the Advice and Guidance (A+G) programme, when poorly designed or inadequately monitored, has contributed to near-misses and actual patient harm — both physical and psychological.

The finding lands at a moment when England’s NHS is under intense pressure to cut waiting lists and streamline cancer pathways. The A+G mechanism was introduced precisely to reduce unnecessary hospital appointments and shorten the time between a GP’s suspicion and specialist input. In theory, a family doctor could phone or message a consultant for a quick opinion rather than triggering a full referral, saving both the patient and the system from a potentially unnecessary hospital visit. The HSSIB acknowledged that the scheme has “positively influenced patient care” by strengthening communication between primary and secondary care, and that it has “enabled efficient specialist input into care.”

How the Scheme Went Wrong

Yet the investigation uncovered evidence that, in practice, A+G has become a bottleneck in cancer pathways. The report states plainly that “harm had arisen as a result of delayed or missed diagnoses, and delays to care and treatment.” In some local areas, hospital trusts began routing suspected-cancer referrals back to GPs as unsolicited A+G requests — effectively rejecting the referral and telling the GP to seek informal specialist advice first. Other pathways made A+G a mandatory step before any direct referral could be accepted, even when the GP had persistent, clinically justified concerns.

The HSSIB noted that “evidence demonstrated that A+G services were being used in some pathways where general practice had requested specialist assessment for suspected cancer,” and that “incidents demonstrated that this had contributed to delays in diagnosis.” In practical terms, a patient whose GP suspected a malignancy could find themselves caught in an administrative loop: the hospital would not accept the referral, the GP would be told to obtain informal specialist guidance first, and weeks could pass before that guidance arrived — or before the GP felt empowered to re-refer.

Implementation Gaps and Systemic Weaknesses

Beyond individual incidents, the investigation identified structural gaps in how A+G was rolled out. Training for GPs on when and how to use the service was inconsistent. Reporting mechanisms for patient-safety incidents linked to A+G were weak, meaning many near-misses likely went unrecorded. Resource and capacity mismatches between primary and secondary care meant that some trusts simply lacked the specialist bandwidth to respond to A+G queries within clinically appropriate timeframes.

The HSSIB recommended that NHS England and the Department of Health and Social Care conduct a rapid, comprehensive evaluation of A+G services to close these gaps — addressing capacity shortfalls, training deficits, and the absence of robust incident-reporting infrastructure.

“A+G services are making a real difference for patients in many parts of the NHS, and we heard genuine enthusiasm for what they can achieve. But we also heard serious concerns, and found evidence of harm where implementation has not been adequately designed or monitored. Our recommendations are about ensuring that expansion happens safely with the right support, standardisation and oversight in place to ensure patient safety is a priority.” — Dr Nick Woodier, senior safety investigator, HSSIB

NHS England Responds

NHS England accepted the report’s findings while emphasising the scheme’s benefits. A spokesperson stated:

“As HSSIB acknowledges, advice and guidance has positively influence patient care by reducing waiting times and giving people quicker access to specialist advice, but we know more needs to be done to make it work even more effectively. That is why we’re giving GPs and hospitals clear guidance and practical tools to help deliver the service safely, consistently and effectively across the NHS, and have already commissioned an evaluation of its impact which will be published this year.”

GP Survey Data Corroborates the Findings

The HSSIB report arrived alongside independent survey data that sharpen the picture. A Pulse survey of 712 GPs found that roughly one in four patient referrals was being rejected and returned as an unsolicited A+G request. Family doctors also estimated that 36 per cent of the A+G queries they received asked them to perform tasks considered outside their clinical remit — effectively pushing secondary-care decisions back onto primary-care clinicians without adequate support or authority.

Additional survey responses highlighted growing waits for patients with suspected cancer caught in the A+G loop, with some GPs reporting that genuine advice-and-guidance requests took ten days or longer to receive a response from hospital colleagues.

Professional Bodies Sound the Alarm

Dr Clare Bannon, chair of the GPs’ committee at the British Medical Association, framed the findings as confirmation of long-standing frontline anxieties:

“Since its introduction, GPs have expressed deep concern with the advice and guidance system – we know our patients and know when a referral needs to be made. So this report is tragic vindication for these concerns, now showing that patients have come to harm as a result of this rushed-out and inconsistently applied process. Just this week we had GPs telling a survey that a quarter of referrals were being sent back as advice and guidance, while genuine advice and guidance requests were taking 10 days or more for a response. We know the pressures our colleagues in secondary care are facing and it’s clear that this process is not working for either of us, nor our patients. The HSSIB is right to recommend an urgent evaluation of the advice and guidance system to address these clear patient safety risks.”

Why This Matters for Cancer Pathways

England’s NHS cancer pathway is built on the principle that suspected cancers should reach specialist assessment within two weeks of a GP referral. Every administrative step inserted between the GP’s suspicion and the hospital’s acceptance of the referral erodes that window. For tumours where staging changes rapidly — pancreatic, ovarian, colorectal — even a delay of two or three weeks can shift a patient from a curable to an incurable category.

The A+G scheme was never intended to become a gatekeeping mechanism. Its original purpose was to give GPs a fast, informal channel for specialist opinion on ambiguous presentations, reducing the volume of low-yield referrals that congest hospital clinics. The investigation’s central warning is that, without standardised protocols, adequate specialist capacity, and clear escalation rules, a tool designed to speed up care can instead slow it down — and, in the worst cases, cost patients their chance at timely treatment.

The coming NHS England evaluation will determine whether A+G is restructured, tightly constrained, or in some configurations withdrawn from cancer pathways altogether. Until that evaluation lands, the HSSIB’s findings place a clear obligation on commissioners and trust boards: ensure that no patient with a suspected cancer is held up by an administrative process that was never meant to delay diagnosis.